No. 108, Meiliang Road
Mashan Binhu District
Full-time employees: 9,864
|Dr. Ge Li Ph.D.||Founder & Chairman||N/A||N/A||1967|
|Dr. Zhisheng Chen||CEO & Exec. Director||662.06k||N/A||1973|
|Dr. Weichang Zhou||Exec. VP, CTO & Exec. Director||354.42k||N/A||1964|
|Mr. Ming Tu||CFO & Exec. VP||N/A||N/A||1968|
|Ms. Tang Shaogui M.B.A.||VP and Head of Global Communications, Operations, Marketing & ESG||N/A||N/A||N/A|
|Dr. Jijie Gu||Exec. VP & Chief Scientific Officer||N/A||N/A||1966|
|Ms. Eileen Wang||IR Sr. Director||N/A||N/A||N/A|
|Ms. Cong Ding J.D.||VP & Head of Legal Department||N/A||N/A||N/A|
|Ms. Li Xiong||VP & Head of Global HR||N/A||N/A||N/A|
|Mr. Angus Scott Marshall Turner||Sr. VP and Head of Global BD & Alliance Management||N/A||N/A||1968|
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China. WuXi Biologics (Cayman) Inc. is a subsidiary of WuXi Biologics Holdings Limited.
WuXi Biologics (Cayman) Inc.’s ISS governance QualityScore as of 1 May 2022 is 2. The pillar scores are Audit: 3; Board: 9; Shareholder rights: 2; Compensation: 1.